DMII
Drugs Made In America Acquisition II Corp.
10.20$
+0.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +42.3% | -35.8% | +308.5% | +51.4% | -43.9% | -15.0% | – | |
| – | +42.3% | -35.8% | +308.5% | +573.6% | -87.4% | -15.0% | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +0.2% | +1.4% | – | |
| – | – | – | – | – | +0.2% | +1.4% | – | |
| – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.